Page last updated: 2024-10-17

3-hydroxybutyric acid and Experimental Neoplasms

3-hydroxybutyric acid has been researched along with Experimental Neoplasms in 7 studies

3-Hydroxybutyric Acid: BUTYRIC ACID substituted in the beta or 3 position. It is one of the ketone bodies produced in the liver.
3-hydroxybutyric acid : A straight-chain 3-hydroxy monocarboxylic acid comprising a butyric acid core with a single hydroxy substituent in the 3- position; a ketone body whose levels are raised during ketosis, used as an energy source by the brain during fasting in humans. Also used to synthesise biodegradable plastics.

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19905 (71.43)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (14.29)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Ferrere, G1
Tidjani Alou, M1
Liu, P1
Goubet, AG1
Fidelle, M1
Kepp, O1
Durand, S1
Iebba, V1
Fluckiger, A1
Daillère, R1
Thelemaque, C1
Grajeda-Iglesias, C1
Alves Costa Silva, C1
Aprahamian, F1
Lefevre, D1
Zhao, L1
Ryffel, B1
Colomba, E1
Arnedos, M1
Drubay, D1
Rauber, C1
Raoult, D1
Asnicar, F1
Spector, T1
Segata, N1
Derosa, L1
Kroemer, G1
Zitvogel, L1
Poff, AM1
Ari, C1
Seyfried, TN1
D'Agostino, DP1
Patel, MS1
Russell, JJ1
Gershman, H1
Tisdale, MJ2
Brennan, RA1
Tamulevicius, P1
Streffer, C1
Blanke, G1
Luscher, G1
Roeder, LM1
Poduslo, SE1
Tildon, JT1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Pilot Study Evaluating a Ketogenic Diet Concomitant to Nivolumab and Ipilimumab in Patients With Metastatic Renal Cell Carcinoma[NCT05119010]60 participants (Anticipated)Interventional2023-03-24Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

7 other studies available for 3-hydroxybutyric acid and Experimental Neoplasms

ArticleYear
Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade.
    JCI insight, 2021, 01-25, Volume: 6, Issue:2

    Topics: 3-Hydroxybutyric Acid; Animals; Cell Line, Tumor; Combined Modality Therapy; CTLA-4 Antigen; Diet, K

2021
The ketogenic diet and hyperbaric oxygen therapy prolong survival in mice with systemic metastatic cancer.
    PloS one, 2013, Volume: 8, Issue:6

    Topics: 3-Hydroxybutyric Acid; Animals; Blood Glucose; Cell Line, Tumor; Combined Modality Therapy; Diet, Ke

2013
Ketone-body metabolism in glioma and neuroblastoma cells.
    Proceedings of the National Academy of Sciences of the United States of America, 1981, Volume: 78, Issue:11

    Topics: 3-Hydroxybutyric Acid; Acetoacetates; Acetyl-CoA C-Acetyltransferase; Animals; Cell Line; Coenzyme A

1981
Loss of acetoacetate coenzyme A transferase activity in tumours of peripheral tissues.
    British journal of cancer, 1983, Volume: 47, Issue:2

    Topics: 3-Hydroxybutyric Acid; Acetyl-CoA C-Acetyltransferase; Animals; Coenzyme A-Transferases; Culture Tec

1983
Role of acetoacetyl-CoA synthetase in acetoacetate utilization by tumor cells.
    Cancer biochemistry biophysics, 1984, Volume: 7, Issue:2

    Topics: 3-Hydroxybutyric Acid; Acetate-CoA Ligase; Acetoacetates; Animals; Bone Marrow; Cell Line; Cells, Cu

1984
The effects of radiosensitizers on intermediary metabolism in vivo.
    International journal of radiation oncology, biology, physics, 1984, Volume: 10, Issue:8

    Topics: 3-Hydroxybutyric Acid; Acetoacetates; Adenocarcinoma; Animals; Dihydroxyacetone Phosphate; Etanidazo

1984
Utilization of ketone bodies and glucose by established neural cell lines.
    Journal of neuroscience research, 1982, Volume: 8, Issue:4

    Topics: 3-Hydroxybutyric Acid; Acetoacetates; Animals; Astrocytoma; Brain; Cell Line; Cells, Cultured; Gluco

1982